Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
14.09
-0.16 (-1.12%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for MD stock have an average target of 15.36, with a low estimate of 9.00 and a high estimate of 18. The average target predicts an increase of 9.01% from the current stock price of 14.09.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MD stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Macquarie | Macquarie | Buy Initiates $18 | Buy | Initiates | $18 | +27.75% | Dec 16, 2024 |
| Mizuho | Mizuho | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +6.46% | Nov 19, 2024 |
| UBS | UBS | Hold Maintains $11 → $17 | Hold | Maintains | $11 → $17 | +17.10% | Nov 5, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $14 → $18 | Strong Buy | Maintains | $14 → $18 | +27.75% | Nov 5, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $9 → $15 | Hold | Maintains | $9 → $15 | +6.46% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
2.06B
from 1.99B
Increased by 3.13%
Revenue Next Year
2.00B
from 2.06B
Decreased by -2.77%
EPS This Year
1.39
from -0.73
EPS Next Year
1.58
from 1.39
Increased by 13.23%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.1B | 2.2B | 2.1B | |
| Avg | 2.1B | 2.0B | 2.0B | |
| Low | 1.9B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 6.3% | 6.7% | 7.4% | |
| Avg | 3.1% | -2.8% | 2.1% | |
| Low | -3.2% | -10.4% | -4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.47 | 1.72 | 1.79 | |
| Avg | 1.39 | 1.58 | 1.63 | |
| Low | 1.24 | 1.26 | 1.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 23.7% | 13.2% | |
| Avg | - | 13.2% | 3.1% | |
| Low | - | -9.2% | -11.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.